From zero to hero – the rise of Novo Nordisk's best-selling drug
Pharmaceutical giant Novo Nordisk is forever growing, but the drugs that used to drive sales have come and gone over the years. Today, one stands above the rest: quintuple blockbuster Ozempic.
by BENJAMIN WERNER CHRISTENSEN, translated by daniel pedersen
In five years, Novo Nordisk has created a multiple blockbuster drug in diabetes treatment Ozempic, which has been center stage in transforming the Danish pharmaceutical firm’s sales.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Obesity business grows at Novo Nordisk despite Wegovy woes
For subscribers
